Introduction {#sec1}
============

Asthma is one of the chronic airway inflammatory diseases in children and adults, characterized by airway hyper-responsiveness (ARH), reversible airflow obstruction, airway remodeling and recurrent symptoms of wheezing, chest tightness and cough \[[@cit0001]\]. Human asthma is heterogeneous in terms of genetics, severity and in all likelihood pathophysiology \[[@cit0002]\]. An increasing number of studies have demonstrated a significant relationship between genetic polymorphisms of cytokines and asthma susceptibility \[[@cit0003]--[@cit0006]\].

Interleukin-17A (IL-17A) is produced by some types of inflammatory cell, including T helper type-17 (Th17), activated mast cells, NK cells, eosinophils cells, neutrophils cells and basophils cells \[[@cit0007]--[@cit0009]\]. Accumulated studies suggest that IL-17A plays a crucial role in the pathogenesis of asthma. The levels of IL-17 mRNA and/or proteins are found to be elevated in the lungs, sputum and bronchoalveolar lavage fluids from patients with asthma \[[@cit0010], [@cit0011]\]. The elevation of plasma IL-17A level has been further shown to be associated with asthma severity \[[@cit0011]\]. A recent study have demonstrated that IL-17A promotes asthma progression by inducing inflammatory cell migration/infiltration and production of other pro-inflammatory cytokines \[[@cit0012]\].

A number of studies have investigated the association of IL-17A polymorphisms with susceptibility to asthma. Several studies have reported the relationship between IL-17A rs2275913 polymorphism and asthma risk \[[@cit0012]--[@cit0020]\]. Maalmi *et al.* have shown that the G allele of rs2275913 in IL-17A is associated with an increased risk of asthma \[[@cit0012]\]. However, Wang *et al.* failed to find an association between IL-17A rs2275913 polymorphism and asthma risk \[[@cit0016]\]. Due to the contradictory and inconclusive results, we performed this meta-analysis to clarify the correlation between IL-17A rs2275913 polymorphism and asthma risk.

Material and methods {#sec2}
====================

Identification and eligibility of relevant studies {#sec2.1}
--------------------------------------------------

Searches were conducted in PubMed, Web of Science, Elsevier, Google Scholar, Wanfang and Chinese National Knowledge Infrastructure (CNKI) databases to identify available studies published until August 2016. The search terms were: ("interleukin-17" OR "IL-17") AND ("gene" OR "polymorphism" OR "genetic variant") AND ("asthma" OR "asthmatic" OR "bronchial asthma"). Furthermore, the reference lists of the eligible studies were identified. No restrictions were placed on language, population, sample size or publication date.

Inclusion and exclusion criteria {#sec2.2}
--------------------------------

Studies included in this meta-analysis were screened according to the following criteria: (1) a case-control study design, (2) evaluation of the association between IL-17A rs2275913 polymorphism and asthma risk, (3) offered sufficient data to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). The main exclusion criteria of the study were: (1) no usable data offered, (2) non-case-control studies, (3) duplicate papers.

Data extraction {#sec2.3}
---------------

Two reviewers reviewed all eligible studies independently. The following information was collected: first author, year of publication, country, ethnicity, age, numbers of eligible cases and controls, and genotype and allele frequency information. Disagreements were resolved by discussion and consensus.

Statistical analysis {#sec2.4}
--------------------

Hardy-Weinberg equilibrium (HWE) in controls was measured using the χ^2^ test. The strength of the association between IL-17A rs2275913 polymorphism and asthma risk was assessed by ORs and 95% CIs in an allele model (G vs. A), a codominant model (GG vs. AA, GG vs. GA), a dominant model (GG+GA vs. AA) and a recessive model (GG vs. GA+AA) respectively. The statistical significance of the combined ORs was determined by the *Z*-test. The χ^2^ based Cochrane *Q*-test and *I* ^2^ index were used for the assessment of significant heterogeneity between studies (*p* \< 0.10). A random-effects model was performed when heterogeneity was observed in studies. Stratified analyses were adopted by age and ethnicity. Potential publication bias was assessed through Begg's rank correlation test and Egger's linear regression test. The value of *p* \< 0.05 was considered statistically significant, except for tests of heterogeneity (*p* \< 0.10). All statistical analyses were performed with Stata (version 12.0, Stata Corporation, College Station, TX).

Results {#sec3}
=======

Study characteristics {#sec3.1}
---------------------

The detailed process of selection is shown in [Figure 1](#f0001){ref-type="fig"}. In total, 1,386 studies met the search criteria in the initial search of databases. Following screening, ten case-control studies \[[@cit0012]--[@cit0021]\] with 2,510 asthma cases and 2,506 controls were included. As for ethnicity, seven studies investigated Asian populations \[[@cit0013]--[@cit0016], [@cit0018]--[@cit0020]\], two studies investigated African populations \[[@cit0012], [@cit0021]\], and one study investigated a Caucasian population \[[@cit0017]\]. As for age, seven studies investigated children \[[@cit0012]--[@cit0017], [@cit0019]\], and three studies investigated adults \[[@cit0018], [@cit0020], [@cit0021]\]. The genotype frequencies of IL-17A rs2275913 polymorphism in each study are shown in [Tables I](#t0001){ref-type="table"} and [II](#t0002){ref-type="table"}.

###### 

Characteristics of case-control studies included in meta-analysis

  Author    Year   Country    Ethnicity   Age group   Gender   Case (*n*)   Control (*n*)   Genotyping method
  --------- ------ ---------- ----------- ----------- -------- ------------ --------------- -------------------
  Wang      2009   China      Asian       Child       Mix      931          1027            PCR-RFLP
  Chen      2010   China      Asian       Child       Mix      168          205             PCR-RFLP
  Wei       2011   China      Asian       Child       Mix      186          198             PCR-RFLP
  Wang      2011   China      Asian       Child       Mix      287          217             PCR-LDR
  Luo       2013   China      Asian       Adult       Mix      103          48              RT-PCR
  Maalmi    2014   Tunisia    African     Child       Mix      171          171             PCR-RFLP
  Narbutt   2014   Poland     Caucasian   Child       Mix      166          166             PCR-RFLP
  Zeng      2015   China      Asian       Child       Mix      224          150             PCR-RFLP
  Du        2016   China      Asian       Adult       Mix      125          132             PCR-RFLP
  Resende   2016   Portugal   African     Adult       Mix      192          149             RT-PCR

###### 

Distribution of IL-17F genotype among cases and controls

  Studies   Case   Control   HWE *P*-value                     
  --------- ------ --------- --------------- ----- ----- ----- -----------
  Wang      129    234       110             141   251   122   0.6178
  Chen      53     65        50              68    105   32    0.4145
  Wei       53     78        55              62    107   29    0.1160
  Wang      71     151       59              53    110   33    0.0602
  Luo       29     45        29              14    24    10    0.9614
  Maalmi    132    39        0               110   55    6     0.7847
  Narbutt   28     43        12              69    74    10    0.0918
  Zeng      56     120       48              51    82    17    0.0617
  Du        70     60        2               94    21    10    \< 0.0001
  Resende   69     71        8               94    81    17    0.9397

![Flowchart showing the process of study selection](AMS-14-31758-g001){#f0001}

Quantitative synthesis {#sec3.2}
----------------------

The main results of the relationship between IL-17A rs2275913 polymorphism and asthma risk are listed in [Table III](#t0003){ref-type="table"}. Overall, the results indicated a significant association between IL-17A rs2275913 and asthma (G vs. A: OR = 0.866, 95% CI: 0.789--0.951, *p* = 0.003; GG+GA vs. AA: OR = 0.752, 95% CI: 0.633--0.895, *p* = 0.001). However, no significant association was found in the recessive model (GG vs. GA+AA: OR = 0.879, 95% CI: 0.766--1.008, *p* = 0.065) ([Figures 2](#f0002){ref-type="fig"} and [3](#f0003){ref-type="fig"}).

###### 

Summary ORs and 95% CIs for IL-17F rs2275913 polymorphism and asthma risk

  Genetic comparisons   Population   Type of model   Heterogeneity   Test of association                                  
  --------------------- ------------ --------------- --------------- --------------------- --------------- -------------- -------
  G vs. A               Overall      Random          66.9            0.001                 0.866           0.789--0.951   0.003
  Child                 Random       74.8            0.001           0.859                 0.692--1.066    0.167          
  Adult                 Random       41.0            0.183           0.831                 0.692--1.133    0.241          
  Asian                 Random       43.8            0.099           0.794                 0.685--0.921    0.002          
  African               Random       79.6            0.027           1.373                 0.755--2.498    0.299          
  GG+GA vs. AA          Overall      Random          72.3            \< 0.001              0.752           0.633--0.895   0.001
  Child                 Random       72.1            0.001           0.607                 0.403--0.913    0.016          
  Adult                 Random       68.8            0.040           1.594                 0.552--4.603    0.389          
  Asian                 Random       74.1            0.001           0.681                 0.452--1.026    0.066          
  African               Random       48.5            0.164           3.068                 0.461--20.410   0.246          

![Forest plot for the overall association between IL-17A rs2275913 polymorphism and asthma risk under the G vs. A contrast model](AMS-14-31758-g002){#f0002}

![Forest plot for the overall association between IL-17A rs2275913 polymorphism and asthma risk under the GG+GA vs. AA contrast model](AMS-14-31758-g003){#f0003}

In addition, subgroup analysis by age showed that the G allele of rs2275913 in IL-17A was associated with a reduced risk of asthma in children (G vs. A: OR = 0.859, 95% CI: 0.692--1.066, *p* = 0.167; GG+GA vs. AA: OR = 0.607, 95% CI: 0.403--0.913, *p* = 0.016), but not in adults (G vs. A: OR = 0.831, 95% CI: 0.692--1.133, *p* = 0.241; GG+GA vs. AA: OR = 1.594, 95% CI: 0.552--4.603, *p* = 0.389) ([Figures 4](#f0004){ref-type="fig"} and [5](#f0005){ref-type="fig"}).

![Forest plot of the association between IL-17A rs2275913 polymorphism and asthma risk stratified by age under the G vs. A contrast model](AMS-14-31758-g004){#f0004}

![Forest plot of the association between IL-17A rs2275913 polymorphism and asthma risk stratified by age under the GG+GA vs. AA contrast model](AMS-14-31758-g005){#f0005}

Furthermore, subgroup analysis by ethnicity revealed that the G allele of rs2275913 in IL-17A was associated with a reduced risk of asthma in Asians (G vs. A: OR = 0.794, 95% CI: 0.685--0.921, *p* = 0.002; GG+GA vs. AA: OR = 0.681, 95% CI: 0.452--1.026, *p* = 0.066). However, no association was found in Africans (G vs. A: OR = 1.373, 95% CI: 0.755--2.498, *p* = 0.299; GG+GA vs. AA: OR = 3.068, 95% CI: 0.461--20.410, *p* = 0.246) ([Figures 6](#f0006){ref-type="fig"} and [7](#f0007){ref-type="fig"}).

![Forest plot of the association between IL-17A rs2275913 polymorphism and asthma risk stratified by ethnicity under the G vs. A contrast model](AMS-14-31758-g006){#f0006}

![Forest plot of the association between IL-17A rs2275913 polymorphism and asthma risk stratified by ethnicity under the GG+GA vs. AA contrast model](AMS-14-31758-g007){#f0007}

Heterogeneity, sensitivity and publication bias analysis {#sec3.3}
--------------------------------------------------------

Among the four genetic models, significant heterogeneity was observed in the allele model (G allele vs. A allele) and dominant model (GG+GA vs. AA) with a *p* \< 0.10. After stratifying by age and ethnicity, heterogeneity was still significant in adults, children, Asians and Africans ([Table III](#t0003){ref-type="table"}). Sensitivity analysis was conducted to assess the stability of the results. No material alterations were detected, suggesting the reliability of our results. Furthermore, no significant publication bias was detected by Begg's test or Egger's test (all *p* \> 0.05).

Discussion {#sec4}
==========

To the best of our knowledge, this is the first meta-analysis to assess the effect of IL-17A rs2275913 polymorphism on risk of asthma. In the present study, ten studies with a total of 5,016 participants (2,510 asthma cases and 2,506 controls) were ultimately identified. The results of this meta-analysis indicate that the G allele of rs2275913 in IL-17A is a protective factor for the development of asthma.

In subgroup analysis by age and ethnicity, the G allele of rs2275913 in IL-17A is significantly associated with a reduced risk of asthma in children and Asians.

Numerous studies have indicated that IL-17A plays an important role in the development of infections, autoimmune diseases, tumors and allergic disorders, including asthma \[[@cit0022]--[@cit0024]\]. It has been shown that IL-17A stimulates the production of a variety of inflammatory mediators, including cytokines, chemokines and adhesion molecules, by bronchial epithelial cells and endothelial cells \[[@cit0025]\]. Meanwhile, IL-17A induces accumulation of multiple inflammatory cells in the airway mucosa and submucosa to promote asthma development \[[@cit0026], [@cit0027]\]. In addition, IL-17A has been demonstrated to be a potent factor causing airway remodeling by inducing the release of remodeling-associated cytokines (including IL-6, IL-8, IL-11, GM-CSF and VEGF) from airway epithelial cells, endothelial cells and fibroblasts, which promote secretion of mucins by goblet cells, enhance migration/proliferation of airway smooth muscle (ASM) cell and inhibit apoptosis of ASM cells \[[@cit0028]--[@cit0033]\]. Taken together, IL-17A both initiates and aggravates the pathological process of asthma.

The human IL-17A gene is located on chromosome 6p12.1 \[[@cit0034]\]. The a allele of rs2275913 in the promoter region of the IL-17 gene has been reported to be associated with risk of ulcerative colitis \[[@cit0035]\], gastric cancer \[[@cit0036]\] and atopic dermatitis \[[@cit0017]\]. The a allele of rs2275913 enhances IL-17A promoter activity and promotes its transcription, leading to enhanced inflammation in the airway \[[@cit0037]\]. However, conflicting research results have been reported on the association between IL-17A rs2275913 polymorphism and IL-17A production. Maalmi *et al*. \[[@cit0012]\] have found that patients with GG genotype demonstrate mild-to-moderate asthma and low IL-17 levels. Chen *et al.* \[[@cit0014]\] have shown that IL-17A rs2275913 polymorphism does not affect IL-17A expression level in peripheral blood mononuclear cells (PBMCs).

In this meta-analysis, a more precise conclusion was provided by combining all eligible case-control studies. The results showed that the G allele of rs2275913 in IL-17A was significantly associated with a reduced risk of asthma. Furthermore, subgroup analysis by age showed that the G allele of rs2275913 in IL-17A was associated with a reduced risk of asthma in children, but not in adults. Asthma is believed to be a multifactorial disorder affected not only by genetic predisposition but also by environmental factors \[[@cit0038], [@cit0039]\]. The discrepancy between children and adults may be caused by the different duration of exposure of asthma patients to environmental risk factors (including contacting allergens and stimulating factors, air pollution, smoking, and occupational exposure) \[[@cit0040]\]. Subgroup analysis by ethnicity revealed that the G allele of rs2275913 in IL-17A was a protective factor against asthma in Asians, and no association was found in Africans, suggesting that ethnicity affects asthma susceptibility by cytokine polymorphisms, such as IL-17A rs2275913 polymorphism.

Several potential limitations in this meta-analysis should be considered. Firstly, the limited number of studies that qualified for inclusion may lead to relatively insufficient power. Secondly, the majority of the included studies were conducted in Asians and children, with a lack of data from other ethnicities and adults. Thirdly, significant heterogeneity was found between studies. After subgroup analysis by age and ethnicity, the heterogeneity was dramatically reduced for adults, suggesting that a number of factors including differences in age, gender, environment and lifestyle factors affected heterogeneity.

In conclusion, this meta-analysis indicates that the G allele of rs2275913 in IL-17A acts as a protective factor for the development of asthma. Further large-scale and well-designed studies are still needed to confirm our findings.
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